1 completed, 1 terminated. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 1, Terminated 1 |
| Phase 2 | 1 | Terminated 1 |
Follow Recurrent Malignant Peripheral Nerve Sheath Tumor: new trials by email Literature Review of Recurrent Malignant Peripheral Nerve Sheath Tumor trials Research Report on Recurrent Malignant Peripheral Nerve Sheath Tumor
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Vaccine Therapy in Treating Patients with Malignant Peripheral Nerve Sheath Tumor That is Recurrent or Cannot Be Removed by Surgery Computed Tomography, Laboratory Biomarker Analysis, Oncolytic Measles Virus Encoding Thyroidal Sodium Iodide Symporter - Metastatic Malignant Peripheral Nerve Sheath Tumor, Neurofibromatosis Type 1 | Phase 1 | Completed | Mayo Clinic | 9 | 2017-03-22 | 2024-09-27 |
| Sapanisertib or Pazopanib Hydrochloride in Treating Patients With Locally Advanced or Metastatic Sarcoma Pazopanib, Pazopanib Hydrochloride, Sapanisertib - High Grade Sarcoma, Metastatic Leiomyosarcoma | Phase 1 / Phase 2 | Terminated | National Cancer Institute (NCI) | 151 | 2015-11-30 | 2022-08-23 |
Neurofibrosarcoma (2) · Dermatofibrosarcoma (1) · Histiocytoma, Malignant Fibrous (1) · Leiomyosarcoma (1) · Neurofibromatosis 1 (1) · Sarcoma, Synovial (1)
Fibrosarcoma (2) · Neoplasms (2) · Neoplasms by Histologic Type (2) · Neoplasms, Connective Tissue (2) · Neoplasms, Connective and Soft Tissue (2) · Neoplasms, Fibrous Tissue (2) · Neoplasms, Nerve Tissue (2) · Nerve Sheath Neoplasms (2) · Nervous System Diseases (2) · Nervous System Neoplasms (2) · Neurofibroma (2) · Neuromuscular Diseases (2) · Peripheral Nervous System Diseases (2) · Peripheral Nervous System Neoplasms (2) · Sarcoma (2)
Biopsy (1) · High-Energy Shock Waves (1) · Magnetic Resonance Spectroscopy (1) · Photons (1) · Specimen Handling (1) · X-Rays (1) · pazopanib (1) · sapanisertib (1)
Mayo Clinic (1) · National Cancer Institute (NCI) (1)
United States (2)
Dusica Babovic-Vuksanovic, MD (1) · William D Tap (1)
U10CA180821 (1)